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Abstract
The hunt for the genetic contributors to complex
disease has used a number of strategies, resulting in
the identification of variants associated with many of
the common diseases affecting society. However
most of the genetic variants detected to date are
single nucleotide polymorphisms (SNPs) and copy
number variants (CNVs) and fall far short of explaining
the full genetic component of any given disease. An
as yet untapped genomic mechanism is somatic gene
conversion and deletion, which could be complicit in
disease risk but has been challenging to detect in
genome-wide datasets. In a recent publication in BMC
Medicine by Kenneth Ross, the author uses existing
datasets to look at somatic gene conversion and
deletion in human disease. Here, we describe how
Ross’s recent efforts to detect such occurrences could
impact the field going forward.
See research article: http://www.biomedcentral.com/
1741-7015/9/12/abstract
Introduction
It is well established that genetic diversity combined
with specific environmental exposures contribute to dis-
ease susceptibility. However, it has turned out to be
challenging to isolate the genes underlying the genetic
component conferring susceptibility to most complex
disorders. The genetic underpinnings of such traits have
remained largely unsolved until relatively recently,
where the advent of array-based technologies and large
population cohorts have enabled investigators to lever-
age genetic variation across the entire genome to pin-
point major contributing genetic factors. These
discoveries have been primarily driven by genome-wide
association studies (GWAS) using single nucleotide
polymorphism (SNP) markers, which have revealed
compelling evidence, including robust replication, for
genetic variants associated with a broad range of pheno-
types (see full catalogue at http://www.genome.gov/
gwastudies).
These studies have been driven by arrays capable of
estimating chromosomal quantitative data as well as
SNP genotype status. As such, it has been possible to
accurately genotype and rapidly quantify copy number
variants (CNVs) [1-3], which have now been strongly
implicated in common disorders such as autism [4-7],
attention deficit hyperactivity disorder [8], schizophrenia
[9-11] and childhood obesity [12].
Nonetheless, these approaches to date have generally
only captured a small proportion of the predicted
genetic component of various complex traits [13]. It is
widely accepted that more extensive meta-analyses and
high-throughput sequencing efforts with thousands of
DNA samples from affected subjects could lead to
further progress. However, these approaches will require
large collaborative efforts and robust financial invest-
ment, respectively.
While advances are taking place on these fronts, the
question remains of whether there are ways that the
existing genome-wide SNP datasets could be mined
further. After all, many datasets have been deposited in
the public domain, most notably those found on dbGaP
(http://www.ncbi.nlm.nih.gov/gap). The Wellcome Trust
Case Control Consortium (WTCCC) has also made its
datasets available to the wider scientific community and
has been a key leader in whole genome genetic
approaches [14,15].
In a study published this month in BMC Medicine
[16], Kenneth Ross has made use of the WTCCC gen-
ome-wide SNP datasets for 7 common diseases, along
with a shared pool of 3,000 controls to ask a focused
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but alternative question. Rather than looking for genetic
polymorphisms residing in the germ line, he was inter-
ested in uncovering evidence of postzygotic somatic
alterations, namely gene conversions and deletions, con-
tributing to the pathogenesis of these diseases. Mitotic
gene conversions have been shown to arise as a result of
double-strand break repair that uses non-allelic homolo-
gous regions [17]. The effects of somatic gene conver-
sion (see Glossary) have been shown to render genes
non-functional, impact methylation status and aid the
generation of deletions and other copy number variants;
indeed, gene conversion has already been implicated in
a number of disease settings [17-19].
The reason the approach described is so novel is that
detecting these nearly identical recombinants has been
technically difficult, due to both technological shortcom-
ings faced by assessing close to identical sequences and
difficulties associated with detecting such rare events in
the face of a high background ‘wild-type’ signal.
Ross used the rationale that the genotyping data from
most individuals in the WTCCC dataset were derived
from blood, representing a population of cells, and that
somatic gene conversion in an individual would result in
a subtle shift of allele frequency data for an informative
SNP. Since these relatively modest alterations can be
difficult to detect at the individual level, he assessed
whether there were statistical differences in the distribu-
tion of the frequency shifts between multiple control
and disease populations. To help refine SNPs that were
relevant to gene conversion, he used several additional
strategies, including limiting analysis to those SNPs
associated with regions of homology, and focusing on
genotype frequencies that demonstrated unexpected
deviation from Hardy-Weinberg equilibrium.
As a consequence of this study design, the author
detected multiple instances of putative somatic gene
conversion with duplicon identity. Although there is no
experimental validation of the detected conversions, the
author uses various metrics to assign relative strengths
of certainty to the findings. He goes on to speculate on
loci impacted by gene conversion and how they may be
playing a role in disease.
Although the identified gene conversion is limited to
blood, previous data has suggested that significant differ-
ences in sister chromatid exchange have been demonstrated
in blood from patients with diseases in the WTCCC cohort
[15]. Only one of the datasets was from lymphoblastoids
and somewhat surprisingly these control samples did not
show large differences from the blood genotyped controls.
This approach provides a new complementary metho-
dology to detect gene conversion for regions where the
CNV status has been previously characterized. This
technique will, however, be somewhat more limited for
variability still to be defined in specific individuals;
indeed currently available genomic sequencing data sug-
gests that such variability is extensive.
With these caveats in mind, and the fact that the ana-
lyses were limited to considering homologous regions, it
is clear that this current study is primarily hypothesis
forming, with various loci presented as potentially playing
a role in disease risk. Nonetheless these hypotheses are
testable, and the gene conversions identified by Ross can
be tested in future datasets from DNA derived directly
from target tissues or blood from other replication
cohorts to further clarify their roles in these diseases.
Once replicated, the field can move forward with greater
certainty that perhaps at least one these gene conversion
loci are contributing to disease risk and functional studies
can be carried out to determine mode of action.
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Glossary
Somatic gene conversion
This concept defines the process by which DNA sequence information is
transferred in a non-reciprocal process from one genomic region to
another region of the genome, altering its sequence. The transfer of
genomic information is due to base mismatch repair during the
recombination in somatic division
Duplicons
These are duplicated genomic segments, also known as segmental
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origin and nearly identical sequence present as low copy repeats. The
length of duplicons can vary from 1 kb to hundreds of kb and have a
high level of sequence identity (>90%)
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